Neuropoietins such as leukemia inhibitory factor (LIF) have been shown to ameliorate experimental autoimmune encephalomyelitis (EAE) and promote oligodendrocyte survival in vivo. We tested whether two previously described LIF polymorphisms are associated with MS by genotyping these single nucleotide polymorphisms (SNPs) in a group of MS patients (n = 110), rheumatoid arthritis (RA) patients (n = 120) and healthy controls (HC, n = 109). Similar allele and genotype frequencies for both SNPs were found for all study groups. Furthermore, no associations with MS type or HLA-DR2 expression could be found. In summary, no association was found between the studied LIF DNA polymorphisms and the prevalence of MS indicating that these polymorphisms are not involved in determining disease susceptibility. D
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system in which complex interactions between autoimmune processes, genetic and environmental influences are thought to determine the overall susceptibility (Mcfarlin and Mcfarland, 1982) .
Genes associated with the immune system have received special attention in the search for predisposing genetic factors. In particular, genes that encode for elements of the trimolecular complex (MHC-Ag-TCR) have been studied extensively (Vandevyver et al., 1994; Oksenberg et al., 1989) . While many of these association studies lead to contradictory results, a widely supported association was found with the HLA-DR2 genes (DRB1*1501, DRB5*0101) (Olerup and Hillert, 1991) . In the past few years, extensive genome screens were conducted to identify genes involved in MS susceptibility and pathogenesis. Besides the MHC region on chromosome 6p21, other regions of suggestive linkage (5q, 17q and 22q) were described (Ebers et al., 1996; GAMES and Transatlantic Multiple Sclerosis Genetics Cooperative, 2003; Sawcer et al., 2005) .
Leukemia inhibitory factor, located on chromosome 22q12, is a member of the neuropoietic family of neurotrophins which includes ciliary neurotrophic factor (CNTF), oncostatin M and cardiotrophin-1. The functional relevance of LIF production at sites of brain injury could relate to the ability of LIF to act as a survival factor for neurons and oligodendrocytes (Martinou et al., 1992; Barres et al., 1993) . Butzkueven et al. (2002) have demonstrated that LIF can ameliorate experimental autoimmune encephalomyelitis (EAE) by promoting oligodendrocyte survival in vivo. A dysregulated production of neurotrophins could lead to an inadequate neurobiological defense against immune mediated CNS injury. Giess et al. (2002) showed that MS patients with a homozygous null mutation in the CNTF gene -leading to a truncated, biologically inactive protein -
